Leukemia, Myeloid, Acute
6 competing products in clinical development for Leukemia, Myeloid, Acute.
Pipeline by Phase
Phase 13
Phase 23
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen | CSPC Pharmaceutical Group Limited | Phase 2 | Recruiting | 42 |
| AC220 | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Quizartinib | Daiichi Sankyo | Phase 2 | Completed | 35 |
| AC220 + daunorubicin + cytarabine | Daiichi Sankyo | Phase 1 | Completed | 29 |
| AC220 | Daiichi Sankyo | Phase 1 | Completed | 29 |
| DS-3201b | Daiichi Sankyo | Phase 1 | Terminated | 21 |